²é¿´: 1399  |  »Ø¸´: 8

¿µ½à

гæ (ÕýʽдÊÖ)

[½»Á÷] Ë­ÓÐÓÃÓ«¹â̽Õë²â¹ýÑõ»¯ÇâµÄÎÄÏ×£¨×îºÃÊÇÉúÎïÌåÄÚ£©

Ë­ÓÐÓÃÓ«¹â̽Õë²â¹ýÑõ»¯ÇâµÄÎÄÏ×£¨×îºÃÊÇÉúÎïÌåÄÚ£©
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

brilliant

¾èÖú¹ó±ö (Ö°Òµ×÷¼Ò)

¡ï ¡ï ¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
»ÆÍª: ½ð±Ò+1, лл»ØÌû½»Á÷ 2014-04-28 08:53:33
¿µ½à: ½ð±Ò+1 2014-07-23 10:23:15
2Â¥2014-04-26 05:55:38
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

mzhyan

ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)

¡ï
»ÆÍª: ½ð±Ò+1, лл»ØÌû½»Á÷ 2014-04-27 18:04:12
blessing
3Â¥2014-04-26 06:56:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wbshuai

ľ³æ (ÕýʽдÊÖ)

ÕâÖÖÎÄÏ׺ܶడ
³ÖÖ®ÒԺ㣬ÍòʽԳÉ
4Â¥2014-04-26 08:16:48
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

¿µ½à

гæ (ÕýʽдÊÖ)

ÒýÓûØÌû:
2Â¥: Originally posted by brilliant at 2014-04-26 05:55:38
http://www.nature.com/nprot/journal/v9/n5/abs/nprot.2014.060.html

²»ºÃÒâ˼£¬´ò²»¿ª£¬ÄÜÔÙ¸øÎÒ·¢Ò»´ÎÂð
5Â¥2014-04-27 22:42:29
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

brilliant

¾èÖú¹ó±ö (Ö°Òµ×÷¼Ò)

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
»ÆÍª: ½ð±Ò+1, лл»ØÌû½»Á÷ 2014-04-29 09:19:52
¿µ½à(likedong1021´ú·¢): ½ð±Ò+5, ¸Ðл»ØÌû½»Á÷£¡ 2014-07-28 04:51:19
Nature Protocols | Protocol
PrintEmailShare/bookmark
Cite U LikeFacebookTwitterDeliciousDiggGoogle+LinkedInRedditStumbleUponPrevious articleNature Protocols | Protocol
Monitoring in vivo reversible cysteine oxidation in proteins using ICAT and mass spectrometry Next articleNature Protocols | Protocol
In vivo introduction of transgenes into mouse sciatic nerve cells in situ using viral vectors  

Synthesis, labeling and bioanalytical applications of a tris(2,2¡ä-bipyridyl)ruthenium(II)-based electrochemiluminescence probe
Xiaoming Zhou,1, Debin Zhu,1, Yuhui Liao,1, Weipeng Liu,1, Hongxing Liu,1, Zhaokui Ma1, & Da Xing1,
AffiliationsContributionsCorresponding author Journal name:
Nature Protocols
Volume:
9,
Pages:
1146¨C1159
Year published:
(2014)DOI:
doi:10.1038/nprot.2014.060
Published online17 April 2014 Article toolsFull text

PDF
Synthesis, labeling and bioanalytical applications of a tris(2,2¡ä-bipyridyl)ruthenium(II)-based electrochemiluminescence prob...
Download as PDF (921 KB) View interactive PDF in ReadCube CitationReprintsRights & permissionsArticle metrics
Abstract
Abstract• References• Author information• Supplementary information Assays using probes labeled with electrochemiluminescent moieties are extremely powerful analytical tools that are used in fields such as medical diagnostics, environmental analysis and food safety monitoring, in which sensitive, reliable and reproducible detection of biomolecules is a requirement. The most efficient electrochemiluminescence (ECL) reaction to date is based on tris(2,2¡ä-bipyridyl)ruthenium(II) (Ru(bpy)32+) with tripropylamine (TPrA) as the co-reactant. Here we present a detailed protocol for preparing Ru(bpy)32+ probes and their bioanalytical applications. This protocol includes (i) the synthesis of a biologically active Ru(bpy)32+-N-hydroxysuccinimide (NHS) ester, (ii) its covalent labeling with both antibodies and DNA probes and (iii) the detection and quantification of ECL in a microfluidic system with a paramagnetic microbead solid support. In our magnetic bead¨Cbased ECL system, two probes are required: a capture probe (labeled with biotin to be captured by a streptavidin-coated magnetic bead) and a detector probe (labeled with Ru(bpy)32+). The complex consisting of the analyte, the capture probe, the detector probe and the magnetic bead is brought into contact with the electrode by using a magnetic field. The Ru(bpy)32+ reacts with TPrA in solution to generate the ECL signal. The full protocol, including the synthesis and labeling of the bioactive Ru(bpy)32+, requires 5¨C6 d to complete. ECL immunoassays or nucleic acid tests only require 1.5¨C2 h, including the sample preparation time.
6Â¥2014-04-28 09:28:22
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zqx1990

ľ³æ (ÕýʽдÊÖ)

¡ï ¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
»ÆÍª: ½ð±Ò+1, лл»ØÌû½»Á÷ 2014-04-29 09:20:57
7Â¥2014-04-28 22:00:48
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zqx1990

ľ³æ (ÕýʽдÊÖ)

¡ï ¡ï ¡ï ¡ï ¡ï
»ÆÍª: ½ð±Ò+1, Ó¦ÖúÖ¸Êý+1, лл»ØÌû½»Á÷ 2014-04-29 09:20:37
¿µ½à(likedong1021´ú·¢): ½ð±Ò+4 2014-07-28 04:51:35
In vivo imaging of hydrogen peroxide with chemiluminescent nanoparticles

Dongwon Lee1,5, Sirajud Khaja1,5, Juan C. Velasquez-Castano2, Madhuri Dasari1, Carrie Sun3, John Petros3,4, W. Robert Taylor1,2,4 & Niren Murthy1

Abstract
The overproduction of hydrogen peroxide is implicated in the development of numerous diseases1, 2, 3, 4 and there is currently great interest in developing contrast agents that can image hydrogen peroxide in vivo. In this report, we demonstrate that nanoparticles formulated from peroxalate esters and fluorescent dyes can image hydrogen peroxide in vivo with high specificity and sensitivity. The peroxalate nanoparticles image hydrogen peroxide by undergoing a three-component chemiluminescent reaction between hydrogen peroxide, peroxalate esters and fluorescent dyes. The peroxalate nanoparticles have several attractive properties for in vivo imaging, such as tunable wavelength emission (460¨C630 nm), nanomolar sensitivity for hydrogen peroxide and excellent specificity for hydrogen peroxide over other reactive oxygen species. The peroxalate nanoparticles were capable of imaging hydrogen peroxide in the peritoneal cavity of mice during a lipopolysaccharide-induced inflammatory response. We anticipate numerous applications of peroxalate nanoparticles for in vivo imaging of hydrogen peroxide, given their high specificity and sensitivity and deep-tissue-imaging capability.
8Â¥2014-04-28 22:01:41
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zqx1990

ľ³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÕâÀàÎÄÏױȽ϶àµÄ
9Â¥2014-04-28 22:03:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ѧԱ9yipfZ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] »¯Ñ§µ÷¼Á +5 yzysaa 2026-03-21 5/250 2026-03-21 22:12 by peike
[¿¼ÑÐ] ¿¼Ñе÷¼Á +3 ºôºô£¿~+123456 2026-03-21 3/150 2026-03-21 20:04 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 326Çóµ÷¼Á +5 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 8/400 2026-03-21 19:33 by ColorlessPI
[¿¼ÑÐ] Çóµ÷¼Á +4 ÒªºÃºÃÎÞÁÄ 2026-03-21 4/200 2026-03-21 18:57 by ѧԱ8dgXkO
[¿¼ÑÐ] Çóµ÷¼Á +3 13341 2026-03-20 3/150 2026-03-21 18:28 by ѧԱ8dgXkO
[¿¼ÑÐ] 296Çóµ÷¼Á +4 www_q 2026-03-20 4/200 2026-03-21 17:26 by ѧԱ8dgXkO
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖпƼ¼´óѧ071000£¬Çóµ÷¼Á +3 ÑØ°¶Óб´¿Ç6 2026-03-21 3/150 2026-03-21 10:35 by ÄºÔÆÇ庮
[¿¼ÑÐ] 0856²ÄÁÏר˶353Çóµ÷¼Á +3 NIFFFfff 2026-03-20 3/150 2026-03-21 10:23 by luoyongfeng
[¿¼ÑÐ] Ò»Ö¾Ô¸Ìì½ò´óѧ»¯Ñ§¹¤ÒÕרҵ£¨081702£©315·ÖÇóµ÷¼Á +12 yangfz 2026-03-17 12/600 2026-03-21 03:30 by JourneyLucky
[¿¼ÑÐ] ÄϾ©´óѧ»¯Ñ§376Çóµ÷¼Á +3 hisfailed 2026-03-19 6/300 2026-03-20 23:43 by hisfailed
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤ +8 °²È«Éϰ¶£¡ 2026-03-16 8/400 2026-03-20 22:13 by luoyongfeng
[¿¼ÑÐ] ²ÄÁÏѧ˶297ÒѹýËÄÁù¼¶Çóµ÷¼ÁÍÆ¼ö +11 adaie 2026-03-19 11/550 2026-03-20 21:30 by laoshidan
[¿¼ÑÐ] 295²ÄÁÏÇóµ÷¼Á£¬Ò»Ö¾Ô¸Î人Àí¹¤085601ר˶ +5 Charlieyq 2026-03-19 5/250 2026-03-20 20:35 by JourneyLucky
[¿¼ÑÐ] 085410È˹¤ÖÇÄÜר˶317Çóµ÷¼Á£¨0854¶¼¿ÉÒÔ£© +4 xbxudjdn 2026-03-18 4/200 2026-03-20 09:07 by ²»168
[¿¼ÑÐ] 286Çóµ÷¼Á +6 lemonzzn 2026-03-16 10/500 2026-03-19 14:31 by lemonzzn
[¿¼ÑÐ] 0854£¬¼ÆËã»úÀàÕÐÊÕµ÷¼Á +3 ºúÀ±ÌÀ·ÅÌÇ 2026-03-15 6/300 2026-03-18 12:09 by Éϰ¶Éϰ¶¡­¡­..
[¿¼²©] 26É격 +4 °Ë6°Ë68 2026-03-16 4/200 2026-03-17 13:00 by ÇáËɲ»ÉÙËæ
[¿¼ÑÐ] 302Çóµ÷¼Á +4 С¼Öͬѧ123 2026-03-15 8/400 2026-03-17 10:33 by С¼Öͬѧ123
[ÂÛÎÄͶ¸å] ÓÐûÓдóÀз¢Ð¡ÂÛÎÄÄÜ´øÎÒ¸ö¶þ×÷ +3 ÔöÈñ©ÈË 2026-03-17 4/200 2026-03-17 09:26 by xs74101122
[¿¼ÑÐ] 318Çóµ÷¼Á +3 Yanyali 2026-03-15 3/150 2026-03-16 16:41 by houyaoxu
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û